Rani Therapeutics Holdings, Inc. (RANI) stock forecast and price target
Price $0.53 · data as of November 13, 2026
12-month price target
Average target$7.20
Upside / downside+1268.0%
Analysts5
ConsensusStrong buy
Low $5.00Average $7.20High $11.00
Gold marker: average target · white marker: today’s price ($0.53)
Analyst ratings
Strong buy 1Buy 4Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.17 | +62.8% | $6M |
| Next fiscal year ends December 31, 2027 | $-0.19 | −13.4% | $6M |
| Next quarter ends December 31, 2026 | $-0.04 | +38.1% | $1M |
| Quarter after ends December 31, 2026 | $-0.05 | +28.6% | $850000 |
Consensus of the analysts covering Rani Therapeutics, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Frequently asked questions
What is the Rani Therapeutics stock price target?
The average 12-month target from 5 analysts is $7.20, 1268.0% above the current price of $0.53 Targets range from $5.00 to $11.00.
Is Rani Therapeutics a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 4 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Rani Therapeutics expected to earn?
Analysts expect EPS of $-0.17 for the fiscal year ending December 31, 2026 and $-0.19 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.